NCT01965522View on ClinicalTrials.gov

Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

May 31, 2017

Conditions
Early Stage Breast Cancer
Interventions
DRUG

Melatonin

Melatonin 20mg taken orally once daily. This is in the form of one capsule which contains two pills of melatonin, 10 mg each.

DRUG

Vitamin D

Vitamin D 2000 IU taken orally once daily. This is in the form of one capsule which contains two pills of vitamin D, 1000 IU each.

DRUG

Placebo (melatonin)

Overencapsulated placebo capsule which contains an inert substance. The capsule appears identical to the capsule which contains melatonin tablets.

DRUG

Placebo (vitamin D)

Overencapsulated placebo capsule which contains an inert substance. The capsule appears identical to the capsule which contains vitamin D tablets.

Trial Locations (2)

L8N 1Y3

St Joseph's Healthcare Hamilton, Hamilton

L8V 1C3

Juravinski Cancer Center, Hamilton

All Listed Sponsors
lead

Juravinski Cancer Center

OTHER

NCT01965522 - Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer | Biotech Hunter | Biotech Hunter